Integer Corporation
ITGR | NYSE
$126.38
+$0.10 (+0.08%)
At close: Sep 21, 2026, 4:00 PM ET
$126.38
$0 (0.00%)
After-hours:
Sep 21, 2026, 5:59 PM ET
Company Profile
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Key Executives
| Name | Position |
|---|---|
| Payman Khales | Chief Executive Officer, President & Director |
| Carol Russell | Vice President & Chief Information Officer |
| Diron Smith | Executive Vice President & Chief Financial Officer |
| Andrew Senn | President of Growth & Innovation |
| Jim Stephens | Executive Vice President of Special Projects |
| John Harris | President of Global Operations & Manufacturing Technology |
| Kirk K. Thor | Executive Vice President & Chief Human Resources Officer |
| Kristen Marie Stewart | Director of Investor Relations |
| Lindsay Krause Blackwood | Senior Vice President, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary |
| Sanjiv Arora | Senior Vice President of Strategy, Business Development and Investor Relations |
| Tom Thomas | Vice President, Corporate Controller & Principal Accounting Officer |
| Tony Carr | Executive Vice President of Global Quality & Regulatory Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 03, 2026 | PREM14A | Filing |
| Aug 19, 2026 | DEFA14A | Filing |
| Aug 14, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 04, 2026 | 10-Q | Quarterly Report |
| Aug 04, 2026 | DEFA14A | Filing |
| Aug 04, 2026 | 8-K | Current Report |
| Aug 03, 2026 | DEFA14A | Filing |
| Aug 03, 2026 | DEFA14A | Filing |
| Aug 03, 2026 | DEFA14A | Filing |
| Aug 03, 2026 | DEFA14A | Filing |
Integer Corporation
| Country | United States |
| IPO Date | Sep 28, 2000 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 11,000 |
| CEO | Payman Khales |
Contact Details
5830 Granite Parkway Plano,
Texas 75024 United States
Stock Details
| Ticker Symbol | ITGR |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001114483 |
| CUSIP Number | 45826H109 |
| ISIN Number | US45826H1095 |
| SIC Code | 3690 |
Recent News
- 6 days ago / globenewswire.comITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law
- 21 days ago / businesswire.comInteger Holdings Corporation Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ITGR
- 1 month ago / zacks.comInteger Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline
- 2 months ago / businesswire.comInteger Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Integer Holdings Corporation - ITGR
- 2 months ago / prnewswire.com$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Integer Holdings Corporation (NYSE: ITGR)
- 2 months ago / prnewswire.comShareholder Alert: Ademi LLP investigates whether Integer Holdings Corporation is obtaining a Fair Price for Public Shareholders
- 2 months ago / zacks.comCompared to Estimates, Integer (ITGR) Q2 Earnings: A Look at Key Metrics
- 2 months ago / businesswire.comITGR Stock Alert: Halper Sadeh LLC is Investigating Whether Integer Holdings Corporation is Obtaining a Fair Price for its Shareholders
- 2 months ago / newsfilecorp.comJohnson Fistel Investigates Proposed Sale of Integer Holdings Corporation (ITGR); Encourages Stockholders to Evaluate Their Legal Rights
- 2 months ago / zacks.comInteger (ITGR) Q2 Earnings and Revenues Top Estimates
Add to Watchlist
Select watchlists to add or remove ITGR